NCT01021683
- Conditions
- Agranulocytosis, Body Temperature Changes, Cytopenia, +11 more
- Locations
-
Not specified
Clinical trial condition
Hematologic Neoplasms
Explore clinical trials studying Hematologic Neoplasms. Study availability and eligibility vary by location and protocol.
84 public trials
17 recruiting studies
Hematologic Neoplasms trial results
NCT01275534
- Conditions
- Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +2 more
- Locations
-
- University Hospital Basel Basel, Switzerland
- University Hospital Zürich Zurich, Switzerland
NCT00421213
- Conditions
- Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +14 more
- Locations
-
- Miami, Florida, United States
- Chicago, Illinois, United States
- Bethesda, Maryland, United States
- Fargo, North Dakota, United States
NCT00389428
- Conditions
- Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +2 more
- Locations
-
- Georgetown University Medical Center Washington D.C., District of Columbia, United States
- H. Lee Moffit Cancer Center & Research Institute at the University of S. Florida Tampa, Florida, United States
- North Shore University Hospital Manhasset, New York, United States
- New York Presbyterian Hospital Weill Medical College of Cornell University New York, United States
Completed
Safety And Pharmacology Of SNX-5422 Mesylate In Subjects With Refractory Hematological Malignancies
NCT00595686
- Conditions
- Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +2 more
- Locations
-
- Pfizer Investigational Site Augusta, Georgia, United States
- Pfizer Investigational Site Chapel Hill, North Carolina, United States
- Pfizer Investigational Site Pittsburgh, Pennsylvania, United States
- Pfizer Investigational Site Nashville, Tennessee, United States
Completed
Umbilical Cord Blood Stem Cell Transplantation in Adults With Advanced Blood Disorders or Cancer
NCT00312429
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +22 more
- Locations
-
- Duke University Durham, North Carolina, United States
NCT00987987
- Conditions
- Disease Attributes, Hematologic Diseases, Hematologic Neoplasms, +7 more
- Locations
-
- Hopital Henri Mondor Créteil, France
NCT00473577
- Conditions
- Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +2 more
- Locations
-
- University of Chicago Chicago, Illinois, United States
NCT00001748
- Conditions
- Bone Marrow Diseases, Chronic Disease, Disease Attributes, +25 more
- Locations
-
- National Heart, Lung and Blood Institute (NHLBI) Bethesda, Maryland, United States
NCT00067730
- Conditions
- Hematologic Diseases, Hematologic Neoplasms, Hematopoietic Stem Cell Transplantation, +10 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Denver, Colorado, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Iowa City, Iowa, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Manhassaet, New York, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Durham, North Carolina, United States